Adesso enters multi-year contract with Novartis

NewsGuard 100/100 Score

Adesso Solutions, the leader in integrated technology solutions for the Consumer Goods industry, today announced that a new multi-year contract has been signed with global pharmaceutical leader, Novartis AG. The agreement extends an existing relationship with Adesso Solutions and confirms they will continue to provide trade planning and execution, check request processing, and deduction management software solutions to both the US and Canadian Divisions.

“Novartis sees the value in the SaaS software model and ERP-integrated solutions, and we expect this will be the continuation of a very robust, long-term, and mutually beneficial relationship”

Previously, Novartis was a long-time Gelco customer and thanks to tight collaboration between client and vendor, was successfully transitioned to the new Adesso Solutions' Microsoft platform last Fall. "Novartis sees the value in the SaaS software model and ERP-integrated solutions, and we expect this will be the continuation of a very robust, long-term, and mutually beneficial relationship," said David Skerke, V.P. of Client Services at Adesso Solutions. "Novartis understands the importance of continually looking for efficiencies and business process improvements. We are excited to provide Novartis with solutions that support their business growth."

This multi-year commitment between Adesso Solutions and Novartis AG provides a platform for continued collaboration regarding future product features and business process automation enhancements at Novartis.

Source:

Adesso Solutions,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sapio Sciences Unveils Enhanced Molecular Biology Toolkit